Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
KouKuiQing lozenge is a Traditional Chinese Medicine (TCM) herbal formulation developed by Guizhou Bailing Group Pharmaceutical for the treatment of recurrent aphthous stomatitis (canker sores). It is specifically indicated for patients presenting with the heart–spleen heat syndrome according to TCM principles. The drug is formulated as a lozenge for local application in the oral cavity to promote ulcer healing, reduce pain, and prevent recurrence. Clinical evaluation has focused on its efficacy in improving ulcer healing rates and reducing the time to recovery in adults with mild recurrent aphthous ulcers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on KouKuiQing lozenge.